company background image
500126 logo

Procter & Gamble Health BSE:500126 Stock Report

Last Price

₹5.06k

Market Cap

₹84.0b

7D

0.03%

1Y

-1.3%

Updated

23 Jun, 2024

Data

Company Financials

Procter & Gamble Health Limited

BSE:500126 Stock Report

Market Cap: ₹84.0b

500126 Stock Overview

Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.

500126 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends4/6

Rewards

Risk Analysis


Procter & Gamble Health Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Procter & Gamble Health
Historical stock prices
Current Share Price₹5,061.65
52 Week High₹5,640.00
52 Week Low₹4,640.30
Beta0.50
11 Month Change5.33%
3 Month Change3.56%
1 Year Change-1.31%
33 Year Change-13.51%
5 Year Change23.27%
Change since IPO123,054.50%

Recent News & Updates

Recent updates

Shareholder Returns

500126IN PharmaceuticalsIN Market
7D0.03%-1.7%-0.1%
1Y-1.3%50.6%46.3%

Return vs Industry: 500126 underperformed the Indian Pharmaceuticals industry which returned 50.6% over the past year.

Return vs Market: 500126 underperformed the Indian Market which returned 46.3% over the past year.

Price Volatility

Is 500126's price volatile compared to industry and market?
500126 volatility
500126 Average Weekly Movement2.5%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement6.5%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 500126 has not had significant price volatility in the past 3 months.

Volatility Over Time: 500126's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19671,407Milind Thattewww.pghealthindia.com

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands.

Procter & Gamble Health Limited Fundamentals Summary

How do Procter & Gamble Health's earnings and revenue compare to its market cap?
500126 fundamental statistics
Market cap₹84.02b
Earnings (TTM)₹2.14b
Revenue (TTM)₹11.69b

39.3x

P/E Ratio

7.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500126 income statement (TTM)
Revenue₹11.69b
Cost of Revenue₹3.67b
Gross Profit₹8.02b
Other Expenses₹5.88b
Earnings₹2.14b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)128.93
Gross Margin68.61%
Net Profit Margin18.31%
Debt/Equity Ratio1.3%

How did 500126 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

78%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.